期刊文献+

仙灵骨葆胶囊治疗围绝经期骨质疏松的疗效观察 被引量:8

暂未订购
导出
摘要 目的观察仙灵骨葆胶囊治疗围绝经期骨质疏松的临床疗效。方法选择该院治疗的围绝经期骨质疏松患者60例,患者均予仙灵骨葆胶囊治疗,治疗后观察临床疗效。治疗前后测定左前臂尺骨鹰嘴至茎突间距远端1/3处骨密度值。结果 60例患者中痊愈15例(25.0%),显效32例(53.3%),有效8例(13.3%),无效5例(8.3%),总有效率为91.7%。治疗前骨密度为(0.542±0.058)g/cm2低于治疗后的(0.685±0.063)g/cm2,差异有统计学意义(P<0.05)。结论仙灵骨葆胶囊治疗围绝经期骨质疏松患者疗效显著,值得临床推广应用。
出处 《临床合理用药杂志》 2014年第7期68-69,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献5

二级参考文献18

  • 1徐丹,袁凤易,王新民.钙与维生素D防治骨质疏松的循证医学研究进展[J].国外医学(内分泌学分册),2005,25(5):338-341. 被引量:16
  • 2中华人民共和国卫生部.中药新药治疗骨质疏松症的临床研究指导原则(S).2002:356-360.
  • 3Lindsay R, Gallagher JC, Kleerekoper M, et al. Bone re- sponse to treatment with lower doses of conjugated estro- gens with and without medroxyprogesterone acetate in early postmenopausal women[J]. Osteoporos Int, 2005,16 (4) :372-379.
  • 4Salpeter SR, Walsh JM, Greyber E, et al. Brief report, cor- onary heart disease events associated with hormone thera- py in younger and older women. A meta-analysis[J]. J Gen Intern Med, 2006,21(4) :363-366.
  • 5Lindsay R, Gallagher JC, Kleerekoper M, et al. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women[J]. JAMA, 2002,287 (20) : 2668- 2676.
  • 6Loke YK,Jeevanantham V,Singh S. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis[J]. Drug Saf, 2009,32 (3) : 219-228.
  • 7Lindsay R, Gallagher JC, Kagan R, et al. Efficacy of tis- sue-selective estrogen complex of bazedoxifene/eonjuga- ted estrogens for osteoporosis prevention in at-risk post- menopausal women[J]. Fertil Steril, 2009,92 (3) : 1045- 1052.
  • 8Cummings SR, San Martin J, McClung MR, et al. Deno- sumab for prevention of fractures in postmenopausal women with osteoporosis[J]. N Engl J Med, 2009,361 (8): 756-765.
  • 9C. H. Chesnut,M. Azria,S. Silverman,M. Engelhardt,M. Olson,L. Mindeholm. Salmon calcitonin: a review of current and future therapeutic indications[J] 2008,Osteoporosis International(4):479~491
  • 10Q. Rehman,T.F. Lang,C.D. Arnaud,G.W. Modin,N.E. Lane. Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis[J] 2003,Osteoporosis International(1):77~81

共引文献26

同被引文献266

引证文献8

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部